Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.
Posted over 1 year ago
Nanocrystals make dentures shine
Research team develops advanced live-imaging approach (w/ video)
Tunable nano-suspensions for light harvesting
Tagging tumors with gold: Scientists use gold nanorods to flag brain tumors
Laser Hardware/Control Software Engineer I (209) - Hanscom AFB, MA
Postdoctoral Position - La Jolla, CA
Research Engineer position in Super-resolution microscopy - Castelldefels (Barcelona), Spain
Physicist/Physical Chemist/Research Engineer (We Sponsor Clearances) - Lexington, MA
AACR 103rd Annual Meeting 2012
Conference on Lasers and Electro-Optics and the...
